About Hospital Abderrahmane Mami
Clinical Trials at Hospital Abderrahmane Mami
During the past decade, Hospital Abderrahmane Mami conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hospital Abderrahmane Mami
According to Clinical.Site data, the most researched conditions in "Hospital Abderrahmane Mami" are
"Acute Respiratory Failure" (1 trials) and "Postoperative Cardiac Complication" (1 trials). Many other conditions were trialed in "Hospital Abderrahmane Mami" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Abderrahmane Mami
Most popular intervention types in "Hospital Abderrahmane Mami" are "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Celiprolol" (1 trials) and "Diltiazem" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Abderrahmane Mami
The vast majority of trials in "Hospital Abderrahmane Mami" are
2 trials for "All" genders.
Clinical Trials Status at Hospital Abderrahmane Mami
Currently, there are NaN active trials in "Hospital Abderrahmane Mami".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Hospital Abderrahmane Mami,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Abderrahmane Mami, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".